Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement

To evaluate the long-term results after transcatheter aortic valve replacement

Completed

Looking for future studies?

Key information

Conditions

Aortic Valve Stenosis Aortic Valve Disease Cardiovascular Diseases Heart Diseases Heart Valve Diseases Ventricular Outflow Obstruction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Ulm

Ulm, 89081, Germany

About this study

Patients with transcatheter aortic valve replacement are followed for 5 years to demonstrate efficacy and safety.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

aortic valve stenosis
transcatheter aortic valve replacement

Exclusion criteria

no written informed consent

Treatment and study plan

CE certified transcatheter ( aortic valve replacement)

Device

Patients receive a transcatheter aortic valve replacement with CE certified transcatheter aortic valves.

Primary outcomes

Major adverse cerebral and cardiac events.

Time frame: 1-5 years

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Acronym: CSI-TAVR

Important dates

Study start: 2014
Primary completion: 2018
Study completion: 2018
First posted: Jun 12, 2014
Registry last updated: Apr 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed